Gufic Biosciences Files FY26 Business Responsibility & Sustainability Report

Gufic Biosciences Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026. The report, filed as per SEBI regulations, details the company's commitment to responsible business practices, governance, and sustainable value creation. It covers environmental stewardship, employee well-being, ethical conduct, and community development initiatives. The company operates primarily in pharmaceutical manufacturing and marketing, with 100% of its turnover from this sector. Exports contributed 23.07% to the total turnover for FY26. Gufic Biosciences has 31 national locations (3 plants, 28 offices) and 3 international offices.